Founded in 2009, Shangqiu Shaohua Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company engaging in the production of APIs, pharmaceutical intermediate, it also manages the pharmaceutical trade and pharmaceutical chemical equipment. The leading products of the company include tropine series: 8-isopropyl-8-azabicyclo[3.2.1]octan-3-one, N-benzyltropinone, tropine, pseudotropine, endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol, nortropine, nortropine hydrochloride, (±)-exo-6-Hydroxytropinone, DL-Tropic acid,2,5-Dimethoxy-2,5-dihydrofuran, mixture ofcis and trans, etc.; ester series: methyl phenylacetate, Ethyl phenylacetate, Ethyl propionate, Ethyl acetate, Diethyl methylmalonate, Diethyl ethylmalonate, Diethyl n-butylmalonate, Diethyl acetamidomalonate, etc.; others include 1,2-Diphenylhydrazine, 6-Ethyl-3-oxa-6-azaoctanol, Carbamimidothioic acid, methyl ester, sulfate, Bromodiphenylmethane,p-Anisidine, 4-Methoxyphenol, etc.The company also produces phenylbutazone, pentoxyverine, indomethacin, gastrodin, atenolol, licorzinc, rutin, trihydroxyethylrutin, probenecid and other APIs.The company is situated in Industrial Zone, Zhecheng County, Shangqiu City, Henan Province, China and it is the key attracting investment enterprise in Zhecheng County. The registered capital is 10 million Yuan RMB, and it covers 110mu, at present, the total investment exceeds 75 million Yuan RMB. We have established 3 workshops for pharmaceutical intermediate, 3 warehouses, equipped with 1 sewage treatment equipment, 1 set of 4T heating boiler, 180 sets of various equipments. The annual output value is 250 million Yuan RMB, and we can absorb about 400 employees from the society.The company has a group of junior and senior technicians and managerial talents engaging in the R&D, production and operation of pharmaceutical, 15 of which have the junior or senior titles, 6 are licensed pharmacists, 35 have the junior title or above, more than 200 have the college degree or above. The company has established cooperation relationships with many research institutes to develop new products and to cultivate new talents. We have also employed the post-doctor Dr. Huang working in the Top 500 companies and Dr. Feng working in domestic university to guide the R&D group and to develop high-tech products. We have established independent R&D base with Shangqiu Normal College Chemical Department. We have various patented technologies.The company has perfect sales network, excellent sales group, stable customer resource, we ceaselessly satisfy the customers' demand by high quality products and favorable credit.We are always insisting on the core value of 'happiness, grateful, integrity, win-win'; and the long-term target of 'international, collectivize, diversified high-tech company'; and the main development direction of 'chemical pharmaceutical intermediate, pharmaceutical, biopharmaceutical, healthy, fashionable products'.Vision of the company: In the next 10 years, the company will strive to be a collectivize, international modern enterprise group by the way of going out, bringing in. In 2021, the gross revenue of the group company will exceed 1000 million Yuan RMB. Meanwhile, the company will also adjust the product structure and emphasize on the development of products of high-tech, high value added, ecological, energy-saving, biotechnological products and fashionable products, and gradually form the product feature and industry advantage and realize the enterprise transformation. We will also create a individualized development platform for the employees and care for the charitable cause. Finally, we will realize the all-win pattern: the prosperous of the enterprise, rich of the employees.